09:55 AM EST - Cynapsus Therapeutics Inc. : announced that its APL-130277 for Parkinson's was recognized as one of the Top 10 Neurology Projects to Watch by a joint selection committee including Dr. Harry Tracy, a noted authority on pharmacological interventions for diseases of the brain. Cynapsus Therapeutics Inc.
shares V.CTH are trading down $0.01 at $0.67.
